Axa’s ICL Group ICL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,779
Closed -$170K 1175
2022
Q3
$170K Buy
+20,779
New +$194K ﹤0.01% 1099
2018
Q4
Sell
-30,000
Closed -$181K 1329
2018
Q3
$181K Buy
+30,000
New +$159K ﹤0.01% 1301
2016
Q3
Sell
-321,880
Closed -$1.25M 1266
2016
Q2
$1.25M Sell
321,880
-280,994
-47% -$1.21M 0.01% 833
2016
Q1
$2.62M Sell
602,874
-176,066
-23% -$726K 0.01% 703
2015
Q4
$3.17M Buy
+778,940
New +$3.91M 0.01% 679

Other funds holding ICL

Axa's ICL Position: Q4 2022 in Review

Axa sold out of ICL Group (ICL) in Q4 2022, closing a stake of 20,779 shares — an estimated $170K sold.

Axa first reported a position in ICL in Q4 2015 and held it in 5 quarters. The position peaked at $3.17M in Q4 2015. 182 funds tracked by Wall St. Rank hold ICL as of Q4 2022.

  • Axa reported no remaining ICL Group position as of Q4 2022 after selling out during the quarter.
  • Axa sold 20,779 ICL Group shares in Q4 2022, an estimated $170K.
  • Axa first reported a position in ICL Group in Q4 2015 and held it in 5 quarters.
  • Axa's ICL Group position peaked at $3.17M in Q4 2015.
  • 182 funds tracked by Wall St. Rank held ICL Group as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.